Accessibility Menu
 
Wuhan General Group (China) logo

Wuhan General Group (China)

(OTC) WUHN

Current Price$0.00
Market Cap$14,400
Since IPO (2007)-100%
5 Year-100%
1 Year+200%
1 Month-25%

Wuhan General Group (China) Financials at a Glance

Market Cap

$14,400

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-9.31 (Low)

Price

$0.00

Volume

1,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

WUHN News

No articles available.

WUHN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Wuhan General Group (China)

Industry

Pharmaceuticals

CEO

Jeff Robinson

Headquarters

Pointe-Claire, QC H9R 0A5, CA

WUHN Financials

Key Financial Metrics (TTM)

Gross Margin

10%

Operating Margin

-119%

Net Income Margin

-121%

Return on Equity

0%

Return on Capital

-3%

Return on Assets

-2%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$14.40K

Shares Outstanding

48.06M

Volume

1.00K

Short Interest

0.00%

Avg. Volume

4.10K

Financials (TTM)

Gross Profit

$1.38K

Operating Income

$1.68M

EBITDA

$1.70M

Operating Cash Flow

$1.66M

Capital Expenditure

$0.00

Free Cash Flow

$1.66M

Cash & ST Invst.

$107.69K

Total Debt

$83.91K

Wuhan General Group (China) Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2022YOY CHG

Revenue

$4.57K

N/A

Gross Profit

$2.08K

N/A

Gross Margin

45.51%

N/A

Market Cap

$14.40K

N/A

Market Cap/Employee

$20.57

N/A

Employees

700

N/A

Net Income

$7.09M

N/A

EBITDA

$7.00M

N/A

Quarterly Fundamentals

Name
Q3 2022YOY CHG

Net Cash

$86.79K

N/A

Accounts Receivable

$13.10K

N/A

Inventory

$15.76K

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$86.79K

N/A

Return on Assets

-2.24%

N/A

Return on Invested Capital

-2.92%

N/A

Free Cash Flow

$189.51K

N/A

Operating Cash Flow

$189.51K

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ARNIArno Therapeutics, Inc.
$0.00+0.00%
AIDAAida Pharmaceuticals, Inc.
$0.00+0.00%
UPPRUpper Street Marketing Inc.
$0.00+0.00%
CENBFCEN Biotech, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$43.87-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
ANNAAleAnna
$7.07+0.87%

Questions About WUHN

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.